Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic body radiation therapy (SBRT) in combination with immunotherapy for oligometastatic esophageal cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Esophageal Cancer | Phase 2 | Status: NOT_YET_RECRUITING